{"product_id":"clinical-psychology-9781118959961","title":"Clinical Psychology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003eThe first book to offer a truly global perspective on the theory and practice of clinical psychology\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eWhile clinical psychology is practiced the world over, up to now there has been no text devoted to examining it within a global context. The first book of its kind, \u003ci\u003eClinical Psychology: A Global Perspective\u003c\/i\u003e brings together contributions from clinicians and scholars around the world to share their insights and observations on the theory and practice of clinical psychology.\u003c\/p\u003e \u003cp\u003eDue partly to language barriers and entrenched cultural biases, there is little cultural cross-pollination within the field of clinical psychology. In fact, most of the popular texts were written for English-speaking European and Anglo-American audiences and translated for other countries. As a result, most psychologists are unaware of how their profession is conceptualized and practiced in different regions, or how their own practices can be enriched by knowledge of the theories and moda\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003eNotes on Contributors xv\u003c\/p\u003e \u003cp\u003ePreface xxiii\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Research Methods 1\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eJulian A. Rubel and Wolfgang Lutz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 1\u003c\/p\u003e \u003cp\u003eResearch on the Frequency, Cause, and Prevention of Psychological Problems, and Disorders 1\u003c\/p\u003e \u003cp\u003eEpidemiology 1\u003c\/p\u003e \u003cp\u003eEtiology and Analytical Epidemiology 2\u003c\/p\u003e \u003cp\u003ePrevention 3\u003c\/p\u003e \u003cp\u003eEvaluating Clinical Interventions and Treatments 3\u003c\/p\u003e \u003cp\u003eDoes the Intervention Work? 4\u003c\/p\u003e \u003cp\u003eExternal Validity 5\u003c\/p\u003e \u003cp\u003eQuantifying the Effects of an Intervention 6\u003c\/p\u003e \u003cp\u003eIntegrating the Results from Multiple Studies—Meta-analyses 7\u003c\/p\u003e \u003cp\u003eIs the Intervention Effective for this Specific Patient? 8\u003c\/p\u003e \u003cp\u003eHow, for Whom, and under which Conditions do Clinical Interventions Work? 10\u003c\/p\u003e \u003cp\u003eSummary 12\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Classification Systems across the Globe 15\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJan Christopher Cwik and Jürgen Margraf\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 15\u003c\/p\u003e \u003cp\u003eClassification Systems in Western Cultures 16\u003c\/p\u003e \u003cp\u003eAtheoretical Classification Systems 16\u003c\/p\u003e \u003cp\u003eThe Diagnostic and Statistical Manual of Mental Disorders (DSM) 16\u003c\/p\u003e \u003cp\u003eThe International Classification of Diseases, Injuries and Causes of Death (ICD) 17\u003c\/p\u003e \u003cp\u003eTheory-based Psychoanalytic and Psychodynamic Classification Systems 18\u003c\/p\u003e \u003cp\u003eClassification Systems in Non-Western Cultures 19\u003c\/p\u003e \u003cp\u003eThe Chinese Classification of Mental Disorders (CCMD) 20\u003c\/p\u003e \u003cp\u003eSpecific Classification Systems 22\u003c\/p\u003e \u003cp\u003eSpecific categorical classification systems 22\u003c\/p\u003e \u003cp\u003eSpecific Noncategorical Classification Systems 23\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Clinical Interviewing with Adults 29\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eChristopher C. Conway, Michelle L. Bourgeois, and Timothy A. Brown\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 29\u003c\/p\u003e \u003cp\u003eGoals of the Clinical Interview 29\u003c\/p\u003e \u003cp\u003eElements of the Clinical Interview 30\u003c\/p\u003e \u003cp\u003eDiagnostic Criteria 30\u003c\/p\u003e \u003cp\u003eRisk Assessment 32\u003c\/p\u003e \u003cp\u003eBehavioral Observation 33\u003c\/p\u003e \u003cp\u003ePsychosocial Assessment 34\u003c\/p\u003e \u003cp\u003eInterviewing Techniques 35\u003c\/p\u003e \u003cp\u003eReliability and Validity of Interviews 36\u003c\/p\u003e \u003cp\u003eIntegrating Cultural Context in Interviews 38\u003c\/p\u003e \u003cp\u003eActuarial Judgment 38\u003c\/p\u003e \u003cp\u003eFunctional Analysis 39\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 40\u003c\/p\u003e \u003cp\u003eSummary 40\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Clinical Interviews with Children and Adolescents 43\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eEva Charlotte Merten and Silvia Schneider\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 43\u003c\/p\u003e \u003cp\u003eClinical Interviews with Children and Adolescents 45\u003c\/p\u003e \u003cp\u003eImplementation of Clinical Interviews 51\u003c\/p\u003e \u003cp\u003eDiagnostics with Children Needs Training! 51\u003c\/p\u003e \u003cp\u003eAge, Age, Age . . . 52\u003c\/p\u003e \u003cp\u003eInterviews with Preschool Children 52\u003c\/p\u003e \u003cp\u003eAre Children Reliable Informants? 53\u003c\/p\u003e \u003cp\u003eDifficulties in Daily Practice 56\u003c\/p\u003e \u003cp\u003eDifficulties on the Patient’s Side 56\u003c\/p\u003e \u003cp\u003eDifficulties regarding Taxonomy 57\u003c\/p\u003e \u003cp\u003eDifficulties on the Diagnostician’s Side 57\u003c\/p\u003e \u003cp\u003eEverything Perfect? How Often are Structured Interviews used in Clinical Practice? 58\u003c\/p\u003e \u003cp\u003eSummary 59\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Psychological Tests 65\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eRobert J. Craig\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 65\u003c\/p\u003e \u003cp\u003ePrinciples and Properties of Psychological Tests 66\u003c\/p\u003e \u003cp\u003eTypes of Psychological Tests 66\u003c\/p\u003e \u003cp\u003eObjective Personality Tests 67\u003c\/p\u003e \u003cp\u003eThe Minnesota Multiphasic Personality Inventory (MMPI\/MMPI-2) 67\u003c\/p\u003e \u003cp\u003eMillon Clinical Multiaxial Inventory (MCMI-III) 69\u003c\/p\u003e \u003cp\u003eThe Personality Assessment Inventory 72\u003c\/p\u003e \u003cp\u003eThe NEO-PI-R 72\u003c\/p\u003e \u003cp\u003eConclusion 73\u003c\/p\u003e \u003cp\u003eProjective Clinical Assessment Instruments 73\u003c\/p\u003e \u003cp\u003eRorschach Inkblot Test 73\u003c\/p\u003e \u003cp\u003eThematic Apperception Test (TAT) 73\u003c\/p\u003e \u003cp\u003eOther Instruments 74\u003c\/p\u003e \u003cp\u003eComputer Test Interpretation 74\u003c\/p\u003e \u003cp\u003eRecent Challenges 75\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 A Global Perspective on Neuropsychological Assessment 81\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eRachel N. Casas, Matthew Calamia, and Daniel Tranel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 81\u003c\/p\u003e \u003cp\u003eOverlapping Histories: Neuropsychological Assessment 82\u003c\/p\u003e \u003cp\u003ePurposes of Neuropsychological Assessment 83\u003c\/p\u003e \u003cp\u003eClassification of Behavior and Cognition in Neuropsychological Assessment 85\u003c\/p\u003e \u003cp\u003eEmotionality 86\u003c\/p\u003e \u003cp\u003eExecutive Functions 87\u003c\/p\u003e \u003cp\u003eNeuropsychological Assessment: Approaches and Methods 87\u003c\/p\u003e \u003cp\u003eApproaches Emphasizing Qualitative Methods 87\u003c\/p\u003e \u003cp\u003eApproaches Emphasizing Quantitative Methods 88\u003c\/p\u003e \u003cp\u003eCritical Considerations for Neuropsychological Assessment in a Global Society 89\u003c\/p\u003e \u003cp\u003eInterpretation of Neuropsychological Assessment Results 91\u003c\/p\u003e \u003cp\u003eFeedback and Recommendations 93\u003c\/p\u003e \u003cp\u003eFuture Directions for Neuropsychological Assessment: A Global Perspective 94\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Culturally Informed Neuropsychological Assessment 99\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eRosemary Toomey\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 99\u003c\/p\u003e \u003cp\u003eThe Field of Clinical Neuropsychology 99\u003c\/p\u003e \u003cp\u003eClinical Neuropsychology Assessment 100\u003c\/p\u003e \u003cp\u003eIntelligence 101\u003c\/p\u003e \u003cp\u003eAchievement 103\u003c\/p\u003e \u003cp\u003eAttention 103\u003c\/p\u003e \u003cp\u003eMemory 103\u003c\/p\u003e \u003cp\u003eLanguage 104\u003c\/p\u003e \u003cp\u003eExecutive Functioning 104\u003c\/p\u003e \u003cp\u003eVisual Spatial 105\u003c\/p\u003e \u003cp\u003eMotor Functioning 105\u003c\/p\u003e \u003cp\u003eCrosscultural Considerations in Clinical Neuropsychology 105\u003c\/p\u003e \u003cp\u003eAre Nonverbal Tests Culture Free? 106\u003c\/p\u003e \u003cp\u003eBilingualism 106\u003c\/p\u003e \u003cp\u003eTranslating Tests 107\u003c\/p\u003e \u003cp\u003eLiteracy 107\u003c\/p\u003e \u003cp\u003eNorming by Race or Country 108\u003c\/p\u003e \u003cp\u003eAcculturation 108\u003c\/p\u003e \u003cp\u003eInteraction of Different Subject Characteristics 109\u003c\/p\u003e \u003cp\u003eChild Neuropsychology 109\u003c\/p\u003e \u003cp\u003eReading Disorder: A Lens through which to View Crosscultural Issues 109\u003c\/p\u003e \u003cp\u003eResearch Study 110\u003c\/p\u003e \u003cp\u003eClinical Case Study 111\u003c\/p\u003e \u003cp\u003eBackground 111\u003c\/p\u003e \u003cp\u003eTest Performance 111\u003c\/p\u003e \u003cp\u003eInterpretation 112\u003c\/p\u003e \u003cp\u003eDiagnosis and Recommendations 112\u003c\/p\u003e \u003cp\u003eSummary 112\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Evidence-Based Treatments: The Debate 119\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eThomas H. Ollendick, Peter Muris, and Cecilia A. Essau\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 119\u003c\/p\u003e \u003cp\u003eDefining Evidence-Based Treatments 120\u003c\/p\u003e \u003cp\u003eEvidence-Based Treatments: The Debate 121\u003c\/p\u003e \u003cp\u003eConclusions 128\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Childhood and Adolescent Disorders 135\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAmie E. Grills and Melissa K. Holt\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eNeurodevelopmental Disorders 136\u003c\/p\u003e \u003cp\u003eIntellectual Disabilities 136\u003c\/p\u003e \u003cp\u003eAutism Spectrum Disorder (ASD) 137\u003c\/p\u003e \u003cp\u003eSpecific Learning Disorder (SLD) 138\u003c\/p\u003e \u003cp\u003eAttention-Deficit\/Hyperactivity Disorder (ADHD) 138\u003c\/p\u003e \u003cp\u003eCommunication Disorders 139\u003c\/p\u003e \u003cp\u003eMotor Disorders 141\u003c\/p\u003e \u003cp\u003eDisruptive, Impulse-Control, and Conduct Disorders 142\u003c\/p\u003e \u003cp\u003eOppositional Defiant Disorder (ODD) 143\u003c\/p\u003e \u003cp\u003eConduct Disorder (CD) 144\u003c\/p\u003e \u003cp\u003eIntermittent Explosive Disorder (IED) 144\u003c\/p\u003e \u003cp\u003eSummary 145\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Mood Disorders 153\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eUlrich Stangier and Elisabeth A. Arens\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eSymptomatology and Classification of Mood Disorders 153\u003c\/p\u003e \u003cp\u003eEpidemiology 156\u003c\/p\u003e \u003cp\u003eDepressive Disorders 156\u003c\/p\u003e \u003cp\u003eBipolar and Related Disorders 157\u003c\/p\u003e \u003cp\u003eAssessment 157\u003c\/p\u003e \u003cp\u003eTreatment 158\u003c\/p\u003e \u003cp\u003eBasic Strategies 158\u003c\/p\u003e \u003cp\u003eBehavioral Activation 160\u003c\/p\u003e \u003cp\u003eCognitive Therapy 161\u003c\/p\u003e \u003cp\u003eInterpersonal Approaches 162\u003c\/p\u003e \u003cp\u003ePsychological Treatments for Recurrent and Persistent Depression 163\u003c\/p\u003e \u003cp\u003ePsychological Treatments for Bipolar Disorder 164\u003c\/p\u003e \u003cp\u003eEmpirical Evidence for the Efficacy of Psychological Treatments in Mood Disorders 165\u003c\/p\u003e \u003cp\u003eConclusions 166\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Anxiety and Obsessive-Compulsive Related Disorders 173\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eKirstyn L. Krause and Martin M. Antony\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eTreatment of Anxiety and Obsessive-Compulsive Related Disorders 173\u003c\/p\u003e \u003cp\u003eOverview of Anxiety and OC-related Disorders 173\u003c\/p\u003e \u003cp\u003eDiagnostic Features 173\u003c\/p\u003e \u003cp\u003eEpidemiological Features 174\u003c\/p\u003e \u003cp\u003eTreatment of Anxiety and OC-Related Disorders 177\u003c\/p\u003e \u003cp\u003ePsychoeducation 177\u003c\/p\u003e \u003cp\u003eMotivational Enhancement 177\u003c\/p\u003e \u003cp\u003eSelf-Monitoring 178\u003c\/p\u003e \u003cp\u003eCognitive Strategies 178\u003c\/p\u003e \u003cp\u003eExposure-Based Strategies 179\u003c\/p\u003e \u003cp\u003eRelaxation-Based Strategies 180\u003c\/p\u003e \u003cp\u003eMindfulness and Acceptance-Based Strategies 181\u003c\/p\u003e \u003cp\u003eHabit Reversal 181\u003c\/p\u003e \u003cp\u003eSocial-Skills Training 182\u003c\/p\u003e \u003cp\u003eProblem-Solving Training 182\u003c\/p\u003e \u003cp\u003ePharmacotherapy 182\u003c\/p\u003e \u003cp\u003ePsychological Treatments for Particular Disorders 183\u003c\/p\u003e \u003cp\u003eCultural Considerations in Treatment 184\u003c\/p\u003e \u003cp\u003eSummary 185\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Posttraumatic Stress Disorder 191\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eRichard A. Bryant\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDefinition 191\u003c\/p\u003e \u003cp\u003ePrevalence of PTSD 193\u003c\/p\u003e \u003cp\u003eThe Course of PTSD 193\u003c\/p\u003e \u003cp\u003eComorbidity 194\u003c\/p\u003e \u003cp\u003eTheoretical Models of PTSD 194\u003c\/p\u003e \u003cp\u003eRisk Factors 195\u003c\/p\u003e \u003cp\u003eTreating PTSD 197\u003c\/p\u003e \u003cp\u003eEarly Intervention for PTSD 198\u003c\/p\u003e \u003cp\u003eComplex PTSD 199\u003c\/p\u003e \u003cp\u003eConclusions 200\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Eating Disorders 209\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eBrunna Tuschen-Caffier and Jennifer Svaldi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ePsychopathology of Eating Disorders 209\u003c\/p\u003e \u003cp\u003eClassification of Eating Disorders 209\u003c\/p\u003e \u003cp\u003eEpidemiology and Comorbidity 211\u003c\/p\u003e \u003cp\u003ePhysical Symptoms and Risks 212\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 212\u003c\/p\u003e \u003cp\u003eAssessment 212\u003c\/p\u003e \u003cp\u003eDevelopment, First Onset and Maintenance Factors 213\u003c\/p\u003e \u003cp\u003eTreatment 215\u003c\/p\u003e \u003cp\u003eCognitive-affective Preparation for Therapy 215\u003c\/p\u003e \u003cp\u003eNutritional Management 217\u003c\/p\u003e \u003cp\u003eImprovement in Body Image Disturbances 218\u003c\/p\u003e \u003cp\u003eEnhancement of Stress Management including Interpersonal Conflict Management 219\u003c\/p\u003e \u003cp\u003eCognitive Interventions 219\u003c\/p\u003e \u003cp\u003eMaintenance of Therapeutic Gains and Prevention of Relapses 220\u003c\/p\u003e \u003cp\u003eEfficacy of Cognitive Behavioral Therapy (CBT) 220\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Sexual Dysfunctions 225\u003c\/b\u003e\u003cbr\u003e\u003ci\u003ePedro J. Nobre\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 225\u003c\/p\u003e \u003cp\u003eClassification of Sexual Dysfunctions 225\u003c\/p\u003e \u003cp\u003ePrevalence of Sexual Dysfunctions 226\u003c\/p\u003e \u003cp\u003eRisk Factors for Sexual Dysfunction 227\u003c\/p\u003e \u003cp\u003eSociodemographic, Relationship and Health Risk Factors 227\u003c\/p\u003e \u003cp\u003ePsychological Factors and Sexual Dysfunction 228\u003c\/p\u003e \u003cp\u003eTrait Factors 228\u003c\/p\u003e \u003cp\u003ePsychological Processing Factors 229\u003c\/p\u003e \u003cp\u003ePsychological Models of Sexual Dysfunction 230\u003c\/p\u003e \u003cp\u003eMasters and Johnson Psychophysiological Model 230\u003c\/p\u003e \u003cp\u003eBarlow’s Cognitive-Affective Model 230\u003c\/p\u003e \u003cp\u003eNobre’s Cognitive-Emotional Model 231\u003c\/p\u003e \u003cp\u003eTreatments for Sexual Dysfunction 231\u003c\/p\u003e \u003cp\u003eReview of Treatment Outcome Studies for Sexual Dysfunction 233\u003c\/p\u003e \u003cp\u003eCognitive Behavioral Therapy for Sexual Dysfunction 234\u003c\/p\u003e \u003cp\u003eCognitive Restructuring 235\u003c\/p\u003e \u003cp\u003eBrief Summary 235\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Couple Distress 243\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eMehmet Sungur\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 243\u003c\/p\u003e \u003cp\u003eWhat are the Processes that Differentiate Functional Couples from Dysfunctional Ones? 244\u003c\/p\u003e \u003cp\u003eAssessment of the Couples 245\u003c\/p\u003e \u003cp\u003eGoal Setting in Couple Therapy 246\u003c\/p\u003e \u003cp\u003eCouple Therapy: Strategies and Techniques 247\u003c\/p\u003e \u003cp\u003eDifficulties with Promoting Change: Difficulties Encountered during Couple Therapy Practice 247\u003c\/p\u003e \u003cp\u003eTreatment Issues: Couple Therapy 249\u003c\/p\u003e \u003cp\u003eTreatment Approaches for Intervention 249\u003c\/p\u003e \u003cp\u003eBehavioral Approaches 250\u003c\/p\u003e \u003cp\u003eCognitive-Behavioral Couple Therapy (CBCT) Approaches 251\u003c\/p\u003e \u003cp\u003eIntegrative Behavioral Couple Therapy (IBCT) 253\u003c\/p\u003e \u003cp\u003eBehavioral Systems Approach to Couple Problems 253\u003c\/p\u003e \u003cp\u003eEmotionally Focused Couple Therapy (EFCT) 254\u003c\/p\u003e \u003cp\u003eStrategic Approaches and Brief Strategic Couple Therapy (BSCT) 255\u003c\/p\u003e \u003cp\u003eSolution-Focused Approaches and Brief Solution-Focused Therapy (BSFT) 255\u003c\/p\u003e \u003cp\u003ePsychoanalytical Approaches 256\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Somatic Symptom Disorders 261\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eMaria Kleinstäuber and Winfried Rief\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 261\u003c\/p\u003e \u003cp\u003eClassifying and Diagnosing SSRD 262\u003c\/p\u003e \u003cp\u003eDiagnostic Categories According to DSM-5, DSM-IV, and ICD-10 262\u003c\/p\u003e \u003cp\u003eSomatic Symptom Disorder (SSD) 262\u003c\/p\u003e \u003cp\u003eIllness Anxiety Disorder 264\u003c\/p\u003e \u003cp\u003eOther SSRD 264\u003c\/p\u003e \u003cp\u003eCritical Reflection on Changes from DSM-IV, and ICD-10 to DSM-5 265\u003c\/p\u003e \u003cp\u003eClassifying Specific Functional Somatic Syndromes 266\u003c\/p\u003e \u003cp\u003eSpecific Cultural Syndromes of Distress 267\u003c\/p\u003e \u003cp\u003eEmpirically Supported Psychological Interventions for SSRD 267\u003c\/p\u003e \u003cp\u003eCognitive Behavior Therapy (CBT) 267\u003c\/p\u003e \u003cp\u003eOther Psychological Interventions for SSRD 273\u003c\/p\u003e \u003cp\u003ePsychodynamic Interpersonal Therapy 273\u003c\/p\u003e \u003cp\u003eGeneral Practitioner (GP) and Reattribution Training 274\u003c\/p\u003e \u003cp\u003eEmpirical Evidence for Psychological Interventions in SSRD 274\u003c\/p\u003e \u003cp\u003eTranscultural Aspects in Psychological Interventions for SSRD 276\u003c\/p\u003e \u003cp\u003eSummary and Conclusion 276\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 Psychotic Disorders 283\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eTania Lincoln\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 283\u003c\/p\u003e \u003cp\u003eDescription of the Disorder 283\u003c\/p\u003e \u003cp\u003eSymptoms 284\u003c\/p\u003e \u003cp\u003eDiagnostic Criteria 285\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 285\u003c\/p\u003e \u003cp\u003eComorbid Disorders and Suicidality 286\u003c\/p\u003e \u003cp\u003eEpidemiology, Course of the Disorder and Prognosis 286\u003c\/p\u003e \u003cp\u003eEtiology 287\u003c\/p\u003e \u003cp\u003eGenetic Risk Factors 287\u003c\/p\u003e \u003cp\u003ePrenatal and Perinatal Risk Factors 287\u003c\/p\u003e \u003cp\u003ePsychosocial Risk Factors 287\u003c\/p\u003e \u003cp\u003ePsychological Models of Explanation: Interplay of Vulnerability, Stressors and Symptoms 288\u003c\/p\u003e \u003cp\u003eNeurochemical Models of Explanation: Excess Dopamine 289\u003c\/p\u003e \u003cp\u003eIntegrative Models: Integrating Genes, Environment, Neurochemistry and Cognitive Schema 290\u003c\/p\u003e \u003cp\u003eAssessment 291\u003c\/p\u003e \u003cp\u003ePharmacological Treatment 291\u003c\/p\u003e \u003cp\u003ePsychological Interventions 293\u003c\/p\u003e \u003cp\u003eCognitive Behavioral Therapy for Psychosis (CBTp) 293\u003c\/p\u003e \u003cp\u003eEmpirical Evidence for CBTp in Schizophrenia 298\u003c\/p\u003e \u003cp\u003eFamily Behavioral Interventions 299\u003c\/p\u003e \u003cp\u003eEffectiveness of Psychoeducational Behavioral Family Interventions 301\u003c\/p\u003e \u003cp\u003eOther Psychological Approaches and their Effectiveness 301\u003c\/p\u003e \u003cp\u003eSummary and Outlook 302\u003c\/p\u003e \u003cp\u003e\u003cb\u003e18 Neurobiology and Pharmacological Treatment of Mental Disorders 309\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eBorwin Bandelow\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 309\u003c\/p\u003e \u003cp\u003eMood Disorders 312\u003c\/p\u003e \u003cp\u003eDepression 312\u003c\/p\u003e \u003cp\u003eBipolar Disorders 314\u003c\/p\u003e \u003cp\u003ePsychotic Disorders 314\u003c\/p\u003e \u003cp\u003eAnxiety Disorders 316\u003c\/p\u003e \u003cp\u003eObsessive-Compulsive Disorder (OCD) 317\u003c\/p\u003e \u003cp\u003ePosttraumatic Stress Disorder (PTSD) 317\u003c\/p\u003e \u003cp\u003eSomatic Symptom Disorders 318\u003c\/p\u003e \u003cp\u003eSubstance-Related Disorders 318\u003c\/p\u003e \u003cp\u003eAlcohol Addiction 318\u003c\/p\u003e \u003cp\u003eOpioid Addiction 319\u003c\/p\u003e \u003cp\u003eDependence on Prescription Drugs 319\u003c\/p\u003e \u003cp\u003eEating Disorders 319\u003c\/p\u003e \u003cp\u003ePersonality Disorders 320\u003c\/p\u003e \u003cp\u003eBorderline Personality Disorder 320\u003c\/p\u003e \u003cp\u003eAntisocial Personality Disorder (ASPD) 320\u003c\/p\u003e \u003cp\u003eDementia 321\u003c\/p\u003e \u003cp\u003eSleep Disorders 321\u003c\/p\u003e \u003cp\u003eAttention-Deficit\/Hyperactivity Disorder (ADHD) 321\u003c\/p\u003e \u003cp\u003eSummary 322\u003c\/p\u003e \u003cp\u003e\u003cb\u003e19 Mindfulness-Based Interventions 327\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eBram Van Bockstaele, Elske Salemink, Brian D. Ostafin, Anne Marie Meijer, and Susan M. Bögels\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ePopular Mindfulness-Based Interventions 327\u003c\/p\u003e \u003cp\u003eMindfulness-Based Stress Reduction 327\u003c\/p\u003e \u003cp\u003eMindfulness-Based Cognitive Therapy 328\u003c\/p\u003e \u003cp\u003eApplication of Mindfulness in Mental Health Care 328\u003c\/p\u003e \u003cp\u003ePsychoeducation Example 329\u003c\/p\u003e \u003cp\u003eMeditation Practice Example 329\u003c\/p\u003e \u003cp\u003eInquiry Example 330\u003c\/p\u003e \u003cp\u003eHomework Example 330\u003c\/p\u003e \u003cp\u003eEffects of Mindfulness-based Interventions on Psychological Disorders 330\u003c\/p\u003e \u003cp\u003eNeurodevelopmental Disorders 330\u003c\/p\u003e \u003cp\u003eSchizophrenia Spectrum and Other Psychotic Disorders 331\u003c\/p\u003e \u003cp\u003eBipolar and Related Disorders 332\u003c\/p\u003e \u003cp\u003eDepressive Disorders 332\u003c\/p\u003e \u003cp\u003eAnxiety Disorders 333\u003c\/p\u003e \u003cp\u003eObsessive-Compulsive and Related Disorders 334\u003c\/p\u003e \u003cp\u003eTrauma- and Stressor-Related Disorders 334\u003c\/p\u003e \u003cp\u003eFeeding and Eating Disorders 335\u003c\/p\u003e \u003cp\u003eSleep-Wake Disorders 336\u003c\/p\u003e \u003cp\u003eSubstance-Related and Addictive Disorders 336\u003c\/p\u003e \u003cp\u003eNeurocognitive Disorders 337\u003c\/p\u003e \u003cp\u003eDiscussion 338\u003c\/p\u003e \u003cp\u003eAcknowledgements 340\u003c\/p\u003e \u003cp\u003e\u003cb\u003e20 Internet-Based Treatments 347\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eGerhard Andersson and Thomas Berger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 347\u003c\/p\u003e \u003cp\u003eAre Internet Treatments Effective? 348\u003c\/p\u003e \u003cp\u003eThe “How” Question 349\u003c\/p\u003e \u003cp\u003eA Research Agenda for the World? 350\u003c\/p\u003e \u003cp\u003eChallenges for the Future 351\u003c\/p\u003e \u003cp\u003eSummary 353\u003c\/p\u003e \u003cp\u003e\u003cb\u003e21 Virtual Reality 361\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eCristina Botella, Rosa M. Baños, Azucena García-Palacios, and Soledad Quero\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 361\u003c\/p\u003e \u003cp\u003eVirtual Reality for the Treatment of Different Psychological Disorders and Health Problems 362\u003c\/p\u003e \u003cp\u003eVirtual Reality as an Ecological Context for Assessing Human Behavior 363\u003c\/p\u003e \u003cp\u003eVirtual Reality as a Realistic Laboratory Setting for Psychopathology 365\u003c\/p\u003e \u003cp\u003eMood-Induction Procedures 365\u003c\/p\u003e \u003cp\u003eStudy of Cognitive Biases 365\u003c\/p\u003e \u003cp\u003eStudy of Psychotic Phenomena 366\u003c\/p\u003e \u003cp\u003eStudy of the Self and Embodiment Processes 367\u003c\/p\u003e \u003cp\u003eVirual Reality Developments for the Treatment of Different Mental and Health Conditions 367\u003c\/p\u003e \u003cp\u003eSpecific Phobias 368\u003c\/p\u003e \u003cp\u003eSocial Anxiety Disorder 369\u003c\/p\u003e \u003cp\u003ePanic Disorder and Agoraphobia 369\u003c\/p\u003e \u003cp\u003eGeneralized Anxiety Disorder 370\u003c\/p\u003e \u003cp\u003eStress-Related Disorders 370\u003c\/p\u003e \u003cp\u003eVirtual Reality in the Treatment of Health Conditions 372\u003c\/p\u003e \u003cp\u003eFuture Perspectives and Ethical Implications of VR 373\u003c\/p\u003e \u003cp\u003eSummary 374\u003c\/p\u003e \u003cp\u003e\u003cb\u003e22 Working Alliance 383\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eNicole Everitt, Brad Cini, and Nikolaos Kazantzis\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eMeasurement 384\u003c\/p\u003e \u003cp\u003eCalifornia Psychotherapy Alliance Scales (CALPAS; Marmar \u0026amp; Gaston, 1988) 384\u003c\/p\u003e \u003cp\u003ePenn Helping Alliance Questionnaire (HAq; Luborsky, 1976) 384\u003c\/p\u003e \u003cp\u003eVanderbilt Therapeutic Alliance Scale (VTAS; Hartley \u0026amp; Strupp, 1983) 384\u003c\/p\u003e \u003cp\u003eWorking Alliance Inventory (WAI) 384\u003c\/p\u003e \u003cp\u003eEvidence for Relations with Outcome 384\u003c\/p\u003e \u003cp\u003eTemporal Precedence 386\u003c\/p\u003e \u003cp\u003eImpact of Alliance Rater and Time of Assessment 386\u003c\/p\u003e \u003cp\u003eAdapting Working Alliance Based on Patient Characteristics 387\u003c\/p\u003e \u003cp\u003eEvidence for Patient Characteristics in Alliance Research 388\u003c\/p\u003e \u003cp\u003eFurther Critique 388\u003c\/p\u003e \u003cp\u003ePatient Matching 389\u003c\/p\u003e \u003cp\u003eThe Therapeutic Relationship is More Than the Working Alliance: The Case of Cognitive Behavior Therapy 389\u003c\/p\u003e \u003cp\u003eCollaboration 390\u003c\/p\u003e \u003cp\u003eConclusion 391\u003c\/p\u003e \u003cp\u003e\u003cb\u003e23 Culture in Clinical Psychology: Adapting Treatments 399\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eAnushka Patel and Devon E. Hinton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eCulture in Clinical Psychology: Adapting Treatments 399\u003c\/p\u003e \u003cp\u003eWhy do we Need Culturally Adapted Treatments? 400\u003c\/p\u003e \u003cp\u003eHow to Adapt: Develop New Treatments or Modify what Works? 401\u003c\/p\u003e \u003cp\u003eEvidence for Efficacy of Cultural Adaptation: What to Adapt 402\u003c\/p\u003e \u003cp\u003eA Model of Anxiety Generation across Cultural Contexts 403\u003c\/p\u003e \u003cp\u003eHow to Culturally Adapt Treatment? 405\u003c\/p\u003e \u003cp\u003eKey Treatment Targets 405\u003c\/p\u003e \u003cp\u003ePsychoeducation and Treatment Engagement 406\u003c\/p\u003e \u003cp\u003eTeaching Emotion Regulation in a Culturally Appropriate Way 408\u003c\/p\u003e \u003cp\u003eCulturally Appropriate Exposure 409\u003c\/p\u003e \u003cp\u003eSummary 411\u003c\/p\u003e \u003cp\u003eIndex 419\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49528842781015,"sku":"9781118959961","price":94.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781118959961.jpg?v=1731873239","url":"https:\/\/bookcurl.com\/products\/clinical-psychology-9781118959961","provider":"Book Curl","version":"1.0","type":"link"}